Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532369) titled 'Occlutech AFR Fontan Study' on April 8.

Study Type: Observational

Primary Sponsor: Occlutech International AB

Condition: Failure of Fontan Type Circulation Fenestration Univentricular Heart Congenital Anomaly

Intervention: Device: Occlutech Atrial Flow Regulator Retrospective Data Collection

Recruitment Status: Not recruiting

Date of First Enrollment: May 1, 2026

Target Sample Size: 25

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07532369

Disclaimer: Curated by HT Syndication....